$NMAD
Nomad Power Solutions, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.53
▲+1.04%+$0.036
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNomad Power Solutions, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is NMAD up today? It is at $3.53 (+1.04%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NMAD spikes, and full due diligence on NMAD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NMAD 11 times in the last 30 days. Create a free account to track $NMAD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NMAD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NMAD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Felix Lourdes Director | Acquired (grant/award) | +30K 0.2% of company | added 100% | 55K | n/a | Jul 1, 26 |
Holloway Michael Andrew Director | Acquired (grant/award) | +15K 0.09% of company | added 60% | 40K | n/a | Jul 1, 26 |
Primus Guy Warren Director | Acquired (grant/award) | +15K 0.09% of company | added 60% | 40K | n/a | Jul 1, 26 |
Pursglove Geordan Garrett Officer | Acquired (grant/award) | +350K 2.2% of company | added 100% | 700K | n/a | Jul 1, 26 |
Sawyer Jason David Director | Acquired (grant/award) | +40K 0.2% of company | added 100% | 65K | n/a | Jul 1, 26 |
Stazzone Peter Officer | Acquired (grant/award) | +50K 0.3% of company | added 100% | 100K | n/a | Jul 1, 26 |
Porter Stuart D Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | May 29, 26 |
Holloway Michael Andrew Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | Apr 15, 26 |
Sawyer Jason David Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | Apr 15, 26 |
Primus Guy Warren Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | Apr 15, 26 |
Pursglove Geordan Garrett Officer | Acquired (grant/award) | +350K 2.2% of company | n/a | 350K | n/a | Apr 15, 26 |
Stazzone Peter Officer | Acquired (grant/award) | +50K 0.3% of company | n/a | 50K | n/a | Apr 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NMAD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NMAD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NMAD last traded at $3.53, up 1.04% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The NMAD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NMAD 11 times in the last 30 days.
NMAD (Nomad Power Solutions, Inc. Common Stock) trades on XNAS, with a market cap of about $56M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NMAD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NMAD discussion
Sign in to ask a question or join the discussion.